Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control.
Zhichen SunZhenhua RenKaiting YangZhida LiuShuaishuai CaoSisi DengLily XuYong LiangJingya GuoYingjie BianHairong XuJiyun ShiFan WangYang-Xin FuHua PengPublished in: Nature communications (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.